These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 16142334
21. Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma. Chau GY, Lee AF, Tsay SH, Ke YR, Kao HL, Wong FH, Tsou AP, Chau YP. Histopathology; 2007 Aug; 51(2):204-18. PubMed ID: 17559540 [Abstract] [Full Text] [Related]
22. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y. Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583 [Abstract] [Full Text] [Related]
23. Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast. Al-Joudi FS, Iskandar ZA, Hasnan J, Rusli J, Kamal Y, Imran AK, Ahmed M, Zakaria J. Singapore Med J; 2007 Jul 15; 48(7):607-14. PubMed ID: 17609820 [Abstract] [Full Text] [Related]
24. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S, Wen SF, Wang L, Kirschmeier P, Bishop WR, Nielsen LL, Pickett CB, Liu S. Oncogene; 2002 Apr 18; 21(17):2613-22. PubMed ID: 11965534 [Abstract] [Full Text] [Related]
25. Survivin expression is regulated by an epigenetic mechanism for DMBA-induced hamster buccal-pouch squamous-cell carcinomas. Chen YK, Hsue SS, Lin LM. Arch Oral Biol; 2005 Jun 18; 50(6):593-8. PubMed ID: 15848153 [Abstract] [Full Text] [Related]
26. Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients. Taubert H, Kappler M, Bache M, Bartel F, Köhler T, Lautenschläger C, Blümke K, Würl P, Schmidt H, Meye A, Hauptmann S. Oncogene; 2005 Aug 04; 24(33):5258-61. PubMed ID: 15856009 [Abstract] [Full Text] [Related]
27. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions. Kleinberg L, Flørenes VA, Nesland JM, Davidson B. Am J Clin Pathol; 2007 Sep 04; 128(3):389-97. PubMed ID: 17709312 [Abstract] [Full Text] [Related]
28. Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy. Végran F, Boidot R, Oudin C, Riedinger JM, Bonnetain F, Lizard-Nacol S. Clin Cancer Res; 2006 Oct 01; 12(19):5794-800. PubMed ID: 17020986 [Abstract] [Full Text] [Related]
29. Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas. Zhang Y, Huang D, Yu G. Acta Otolaryngol; 2005 Dec 01; 125(12):1345-50. PubMed ID: 16303685 [Abstract] [Full Text] [Related]
30. In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma. Takashima H, Nakajima T, Moriguchi M, Sekoguchi S, Nishikawa T, Watanabe T, Katagishi T, Kimura H, Minami M, Itoh Y, Kagawa K, Okanoue T. Liver Int; 2005 Feb 01; 25(1):77-84. PubMed ID: 15698402 [Abstract] [Full Text] [Related]
31. Transcriptional expression of survivin and its splice variants in endometriosis. Fujino K, Ueda M, Takehara M, Futakuchi H, Kanda K, Yamashita Y, Terai Y, Ueki M. Mol Hum Reprod; 2006 Jun 01; 12(6):383-8. PubMed ID: 16644787 [Abstract] [Full Text] [Related]
32. Exonization of Alu-generated splice variants in the survivin gene of human and non-human primates. Mola G, Vela E, Fernández-Figueras MT, Isamat M, Muñoz-Mármol AM. J Mol Biol; 2007 Mar 02; 366(4):1055-63. PubMed ID: 17204284 [Abstract] [Full Text] [Related]
33. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer. Koike H, Sekine Y, Kamiya M, Nakazato H, Suzuki K. Urology; 2008 Dec 02; 72(6):1229-33. PubMed ID: 18336887 [Abstract] [Full Text] [Related]
34. Survivin expression predicts early recurrence in early-stage breast cancer. Yamashita S, Masuda Y, Kurizaki T, Haga Y, Murayama T, Ikei S, Kamei M, Takeno S, Kawahara K. Anticancer Res; 2007 Dec 02; 27(4C):2803-8. PubMed ID: 17695451 [Abstract] [Full Text] [Related]
35. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas. Angileri FF, Aguennouz M, Conti A, La Torre D, Cardali S, Crupi R, Tomasello C, Germanò A, Vita G, Tomasello F. Cancer; 2008 May 15; 112(10):2258-66. PubMed ID: 18327814 [Abstract] [Full Text] [Related]
36. Expression of oestrogen receptor alpha variants in non-malignant breast and early invasive breast carcinomas. Chappell SA, Johnson SM, Shaw JA, Walker RA. J Pathol; 2000 Oct 15; 192(2):159-65. PubMed ID: 11004691 [Abstract] [Full Text] [Related]
37. Differential subcellular localization of functionally divergent survivin splice variants. Mahotka C, Liebmann J, Wenzel M, Suschek CV, Schmitt M, Gabbert HE, Gerharz CD. Cell Death Differ; 2002 Dec 15; 9(12):1334-42. PubMed ID: 12478470 [Abstract] [Full Text] [Related]
38. Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis. Kishi H, Igawa M, Kikuno N, Yoshino T, Urakami S, Shiina H. J Urol; 2004 May 15; 171(5):1855-60. PubMed ID: 15076293 [Abstract] [Full Text] [Related]
39. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Clin Cancer Res; 2000 Jan 15; 6(1):127-34. PubMed ID: 10656440 [Abstract] [Full Text] [Related]
40. Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin. Pizzoferrato E, Liu Y, Gambotto A, Armstrong MJ, Stang MT, Gooding WE, Alber SM, Shand SH, Watkins SC, Storkus WJ, Yim JH. Cancer Res; 2004 Nov 15; 64(22):8381-8. PubMed ID: 15548708 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]